After reconstitution, one dose (0.5 ml) contains: Measles virus1 Enders' Edmonston strain (live, attenuated) not less than 3.00 log10 TCID50*.
Mumps virus1 Jeryl Lynn (Level B) strain (live, attenuated) not less than 4.30 log10 TCID50*.
Rubella virus2 Wistar RA 27/3 strain (live, attenuated) not less than 3.00 log10 TCID50*.
Varicella virus3 Oka/Merck strain (live, attenuated) not less than 3.99 log10 PFU**.
*50% tissue culture infectious dose.
(1) Produced in chick embryo cells.
(2) Produced in human diploid lung (WI‐38) fibroblasts.
(3) Produced in human diploid (MRC‐5) cells.
The vaccine may contain traces of recombinant human albumin (rHA).
This vaccine contains a trace amount of neomycin. See Contraindications.
Before reconstitution, the powder is a white to pale yellow compact crystalline cake and the solvent is a clear colourless liquid.
Excipients with known effect: The vaccine contains 16 mg of sorbitol. See Precautions.
Excipients/Inactive Ingredients: Powder: Sucrose, Gelatin, Sodium chloride, Sorbitol, Monosodium L‐Glutamate Monohydrate, Sodium phosphate, Sodium bicarbonate, Potassium phosphate, Potassium chloride, Medium 199 with Hanks' Salts, Eagle Minimum Essential Medium, Neomycin, Phenol red, Urea.
Solvent: Water for injections.